The circuitous path of PARP inhibitor development in epithelial ovarian cancer

Oncology (Williston Park). 2012 Feb;26(2):144-6.
No abstract available

Publication types

  • Comment

MeSH terms

  • Carcinoma, Ovarian Epithelial
  • Enzyme Inhibitors / therapeutic use*
  • Female
  • Humans
  • Neoplasms, Glandular and Epithelial / drug therapy*
  • Ovarian Neoplasms / drug therapy*
  • Poly(ADP-ribose) Polymerase Inhibitors*

Substances

  • Enzyme Inhibitors
  • Poly(ADP-ribose) Polymerase Inhibitors